Publications & background
Publications on our programs and background literature on our approach and targets
-
BioRxiv
December 2024
Discovery of a Potent and Selective Inhibitor of Human NLRP3 with a Novel Binding Modality and Mechanism of Action
December 2024
-
Bioorganic & Medicinal Chemistry Letters
April 2024
The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening
April 2024
